Informed Prescribing
The practice of prescribing medications based on a thorough understanding of the drug's benefits, risks, alternatives, and the individual patient's circumstances. For peptide drugs with complex mechanisms and specific safety profiles, informed prescribing requires familiarity with the full prescribing information.
Technical Context
Informed prescribing for peptide drugs requires understanding: the drug's mechanism of action and place in therapy, approved indications and off-label evidence, dosing and titration schedules, administration technique (injection training for self-administered drugs), contraindications and precautions, expected and serious adverse effects, drug interactions (particularly the gastric emptying effect of GLP-1 RAs on oral medication absorption), monitoring requirements (HbA1c, weight, renal/hepatic function, calcitonin levels where applicable), and patient counselling points (dose titration rationale, managing GI side effects, injection site rotation, storage requirements). Clinical practice guidelines (ADA/EASD for diabetes, NICE for UK) provide evidence-based frameworks for treatment selection. Shared decision-making with patients — discussing benefits, risks, and alternatives — is a key component.